Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells

Harmonie Perdreau-Dahl, Cinzia Progida, Stefan J Barfeld, Hanne Guldsten, Bernd Thiede, Magnus Arntzen, Oddmund Bakke, Ian G Mills, Stefan Krauss, J Preben Morth

Research output: Contribution to journalArticle

29 Downloads (Pure)

Abstract

Sjögren syndrome/scleroderma autoantigen 1 (SSSCA1) was first described as an auto-antigen over-expressed in Sjögren's syndrome and in scleroderma patients. SSSCA1 has been linked to mitosis and centromere association and as a potential marker candidate in diverse solid cancers. Here we characterize SSSCA1 for the first time, to our knowledge, at the molecular, structural and subcellular level. We have determined the crystal structure of a zinc finger fold, a zinc ribbon domain type 2 (ZNRD2), at 2.3 Å resolution. We show that the C-terminal domain serves a dual function as it both behaves as the interaction site to Tankyrase 1 (TNKS1) and as a nuclear export signal. We identify TNKS1 as a direct binding partner of SSSCA1, map the binding site to TNKS1 ankyrin repeat cluster 2 (ARC2) and thus define a new binding sequence. We experimentally verify and map a new nuclear export signal sequence in SSSCA1.

Original languageEnglish
Pages (from-to)123
JournalCommunications Biology
Volume3
Issue number1
DOIs
Publication statusPublished - 13 Mar 2020

Fingerprint Dive into the research topics of 'Sjögren syndrome/scleroderma autoantigen 1 is a direct Tankyrase binding partner in cancer cells'. Together they form a unique fingerprint.

Cite this